Appendix 4D and Financial Report Dec 2012
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurizon Therapeutics Limited on 6ix
Earlier from Neurizon Therapeutics
- PharmAust Fully Executes Share Sale Agreement With Pitney
- Key Licence Provided by NewSouth Innovations
- Important Discovery in Cancer Therapy
- Clinical Study with PPL-1 Initiated following Approval
- Appendix 4C - Quarterly
Later from Neurizon Therapeutics
- Completion of Share Sale Agreement and Drilling Commenced
- First Two Patients in Canine Clinical Trial Begin Treatment
- Appendix 4C Quarterly Report & Brief Company Update
- Epichem Successful in AusTrade Grant
- University of Cambridge to begin Phase II Trial
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics